Discover
Stocks
Services
ENFN
ENFN
Enfusion
8.37
-0.29
(
-3.35%
)
Market Closed
Delayed Prices By NASDAQ,
in USD
Trade
Buy
ENFN
Enfusion
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Enfusion's revenues increased by 34.60% and amounted to 150.35M. Net income increased by 95.30% to -13.26M. Net assets increased by 6.16% to 103.44M and EPS increased from -2.50 to -0.09.
ENFN's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
67.69%
Net Profit Margin
-30.07%
Operating Margin
7.00%
Return On Investment
-49.02%